Discover

DLB
Dolby Laboratories, Inc.
59.95
300 x 59.53
200 x 60.28
bid
ask
-
0.88
1.45%
250 @ 04:00 PM
59.95 +0.00 (0.00%)
Ytd-6.65%
1y-12.07%
59.49
day range
61.25
48.51
52 week range
69.58
Open61.16Prev Close60.83Low59.49High61.25Mkt Cap5.62B
Vol512.71KAvg Vol915.81KEPS2.35P/E25.51Forward P/E13.10
Beta0.78Short Ratio6.11Inst. Own106.61%Dividend1.44Div Yield2.37
Ex Div Date08-11Earning11-1750-d Avg60.72200-d Avg59.381yr Est79.00

DLB News

Dolby Laboratories Announces Conference Call and Webcast for Q4 Fiscal 2026 Financial Results
prnewswire.com
Dolby Laboratories Announces Conference Call and Webcast for Q4 Fiscal 2026 Financial Results

SAN FRANCISCO, Oct. 12, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB), a leader in immer

Dolby Laboratories (NYSE:DLB) & Palo Alto Networks (NASDAQ:PANW) Financial Contrast
defenseworld.net
Dolby Laboratories (NYSE:DLB) & Palo Alto Networks (NASDAQ:PANW) Financial Contrast

Dolby Laboratories (NYSE: DLB - Get Free Report) and Palo Alto Networks (NASDAQ: PANW - Get Free Rep

Analyzing Dolby Laboratories (NYSE:DLB) & Aware (NASDAQ:AWRE)
defenseworld.net
Analyzing Dolby Laboratories (NYSE:DLB) & Aware (NASDAQ:AWRE)

Dolby Laboratories (NYSE: DLB - Get Free Report) and Aware (NASDAQ: AWRE - Get Free Report) are both

Dolby Laboratories: Weak Growth, But The Valuation Is Too Cheap
seekingalpha.com
Dolby Laboratories: Weak Growth, But The Valuation Is Too Cheap

Dolby Laboratories is rated Buy due to its high margins, robust buyback program, and undervalued sha

Cognition Therapeutics Schedules a Type C Meeting with FDA to Align on Endpoints for Phase 3 Trial of Zervimesine (CT1812) in DLB
globenewswire.com
Cognition Therapeutics Schedules a Type C Meeting with FDA to Align on Endpoints for Phase 3 Trial o

October 20th Meeting with the Division of Neurology Expected to Define Endpoint for Phase 3 October

Dolby Expands Meta Partnership With Atmos and Vision Across Devices
zacks.com
Dolby Expands Meta Partnership With Atmos and Vision Across Devices

DLB expands across Meta's ecosystem as Dolby Atmos and Vision reach AI glasses, Instagram and VR, br

Your Meta AI Glasses Are Getting a Dolby Upgrade
benzinga.com
Your Meta AI Glasses Are Getting a Dolby Upgrade

Meta expands Dolby Atmos & Vision across AI glasses, Instagram, and VR. Get the tech details and

Financial Analysis: Zscaler (NASDAQ:ZS) vs. Dolby Laboratories (NYSE:DLB)
defenseworld.net
Financial Analysis: Zscaler (NASDAQ:ZS) vs. Dolby Laboratories (NYSE:DLB)

Dolby Laboratories (NYSE: DLB - Get Free Report) and Zscaler (NASDAQ: ZS - Get Free Report) are both

Dolby and Meta Expand Dolby Atmos and Dolby Vision Across Meta's Ecosystem
gurufocus.com
Dolby and Meta Expand Dolby Atmos and Dolby Vision Across Meta's Ecosystem

Dolby and Meta Expand Dolby Atmos and Dolby Vision Across Meta's EcosystemPR NewswireSAN FRANCISCO a

Dolby and Meta Expand Dolby Atmos and Dolby Vision Across Meta's Ecosystem
prnewswire.com
Dolby and Meta Expand Dolby Atmos and Dolby Vision Across Meta's Ecosystem

/PRNewswire/ -- Today, Dolby Laboratories (NYSE: DLB) and Meta (NASDAQ: META) announced the expansio

Dolby Laboratories, Inc. Grants Inducement Equity Awards Under Its 2026 Inducement Stock Plan
prnewswire.com
Dolby Laboratories, Inc. Grants Inducement Equity Awards Under Its 2026 Inducement Stock Plan

SAN FRANCISCO, Sept. 15, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB) ("Dolby"), a lead

Dolby Expands Dolby OptiView Platform with New Capabilities at IBC 2026
prnewswire.com
Dolby Expands Dolby OptiView Platform with New Capabilities at IBC 2026

New Sports Intelligence helps providers better understand and deepen fan engagement, as Dolby Vision

Dolby Laboratories (DLB) is a Top-Ranked Growth Stock: Should You Buy?
zacks.com
Dolby Laboratories (DLB) is a Top-Ranked Growth Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t

3 Audio Video Stocks to Watch as the Industry Grapples With Headwinds
zacks.com
3 Audio Video Stocks to Watch as the Industry Grapples With Headwinds

Amid cautious discretionary spending and macro troubles, investments in cutting-edge solutions are l

Dolby Laboratories (DLB) is a Top-Ranked Momentum Stock: Should You Buy?
zacks.com
Dolby Laboratories (DLB) is a Top-Ranked Momentum Stock: Should You Buy?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the

Critical Review: Artificial Life (OTCMKTS:ALIF) & Dolby Laboratories (NYSE:DLB)
defenseworld.net
Critical Review: Artificial Life (OTCMKTS:ALIF) & Dolby Laboratories (NYSE:DLB)

Artificial Life (OTCMKTS:ALIF - Get Free Report) and Dolby Laboratories (NYSE: DLB - Get Free Report

Dolby Laboratories Announces Leadership Transition
prnewswire.com
Dolby Laboratories Announces Leadership Transition

Kevin Yeaman to Retire from Dolby  Marc Whitten Named President, Chief Executive Officer and Directo

Cinemo, Dolby, and SmashLabs Bring In-Car Immersive Gaming Experiences to the Next Level
gurufocus.com
Cinemo, Dolby, and SmashLabs Bring In-Car Immersive Gaming Experiences to the Next Level

Cinemo, a global leader and one-stop-shop provider for fully integrated, innovative multi-device in-

Dividend Champion, Contender, And Challenger Highlights: Week August 16
seekingalpha.com
Dividend Champion, Contender, And Challenger Highlights: Week August 16

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies

Assenagon Asset Management S.A. Has $5.48 Million Position in Dolby Laboratories $DLB
defenseworld.net
Assenagon Asset Management S.A. Has $5.48 Million Position in Dolby Laboratories $DLB

Assenagon Asset Management S.A. increased its stake in shares of Dolby Laboratories (NYSE: DLB) by 8

Here's Why Dolby Laboratories (DLB) is a Strong Growth Stock
zacks.com
Here's Why Dolby Laboratories (DLB) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t

Stock Market Today: Amazon Jumps 15%, Apple Wipes Out $475 Billion
benzinga.com
Stock Market Today: Amazon Jumps 15%, Apple Wipes Out $475 Billion

Amazon surges 15% on an AWS blowout while Apple sheds nearly $475 billion in value. Yields sit at cy

AXT Posts Upbeat Q2 Earnings, Joins Newell Brands, SPX Technologies, Amazon And Other Big Stocks Moving Higher On Friday
benzinga.com
AXT Posts Upbeat Q2 Earnings, Joins Newell Brands, SPX Technologies, Amazon And Other Big Stocks Mov

U.S. stocks mixed, Nasdaq up 50 pts. AXT Inc (NASDAQ: AXTI) rose 25.3% on strong Q2 results. Other g

benzinga.com
Dolby Laboratories Lowers FY2026 GAAP EPS Guidance from $2.66-$2.81 to $2.62-$2.77 vs $2.83 Est

Dolby Laboratories (NYSE:DLB) lowers FY2026 GAAP EPS guidance from $2.66-$2.81 to $2.62-$2.77 vs $2.

benzinga.com
Dolby Laboratories Lowers FY2026 Adj EPS Guidance from $4.30-$4.45 to $4.25-$4.40 vs $4.30 Est; Narr

Dolby Laboratories (NYSE:DLB) lowers FY2026 Adj EPS guidance from $4.30-$4.45 to $4.25-$4.40 vs $4.3

benzinga.com
Dolby Laboratories Sees Q4 Adj EPS $1.13-$1.28 vs $1.20 Est; Sees Sales $362.000M-$392.000M vs $351.

Dolby Laboratories (NYSE:DLB) is looking for Q4 Adj EPS of $1.13-$1.28 vs $1.20 analyst estimate. se

benzinga.com
Dolby Laboratories Q3 Adj. EPS $0.69 Beats $0.67 Estimate, Sales $304.995M Miss $311.960M Estimate

Dolby Laboratories (NYSE:DLB) reported quarterly earnings of $0.69 per share which beat the analyst

Top 3 Tech Stocks That May Rocket Higher In July
benzinga.com
Top 3 Tech Stocks That May Rocket Higher In July

Find bargains in oversold IT stocks with RSI values below 30: Fabrinet (NYSE: FN), Dolby Laboratorie

Stock Market Today: Apple Earnings Power S&P 500, Nasdaq To Records; Trump Hits EU
benzinga.com
Stock Market Today: Apple Earnings Power S&P 500, Nasdaq To Records; Trump Hits EU

U.S. stocks hit fresh records as Apple's blowout Q2 powered Big Tech, while crude oil sank 3% on

Dolby Laboratories Q2 2026 Earnings Call: Complete Transcript
benzinga.com
Dolby Laboratories Q2 2026 Earnings Call: Complete Transcript

12 Information Technology Stocks Moving In Thursday's After-Market Session
benzinga.com
12 Information Technology Stocks Moving In Thursday's After-Market Session

benzinga.com
Dolby Laboratories Sees Q3 Adj EPS $0.56-$0.71 vs $0.98 Est; Sees Sales $295.000M-$325.000M vs $343.

Dolby Laboratories (NYSE:DLB) is looking for Q3 Adj EPS of $0.56-$0.71 vs $0.98 analyst estimate. se

benzinga.com
Dolby Laboratories Lowers FY2026 GAAP EPS Guidance from $2.71-$2.86 to $2.66-$2.81 vs $2.77 Est

Dolby Laboratories (NYSE:DLB) lowers FY2026 GAAP EPS guidance from $2.71-$2.86 to $2.66-$2.81 vs $2.

benzinga.com
Dolby Laboratories Affirms FY2026 Adj EPS Guidance of $4.30-$4.45 vs $4.33 Est; Affirms FY2026 Sales

Dolby Laboratories (NYSE:DLB) affirms FY2026 Adj EPS guidance from $4.30-$4.45 to $4.30-$4.45 vs $4.

benzinga.com
Dolby Laboratories Q2 Adj. EPS $1.37 Beats $1.33 Estimate, Sales $395.630M Beat $385.801M Estimate

Dolby Laboratories (NYSE:DLB) reported quarterly earnings of $1.37 per share which beat the analyst

Earnings Scheduled For April 30, 2026
benzinga.com
Earnings Scheduled For April 30, 2026

benzinga.com
Barrington Research Maintains Outperform on Dolby Laboratories, Maintains $90 Price Target

Barrington Research analyst Patrick Sholl maintains Dolby Laboratories (NYSE:DLB) with a Outperfo

benzinga.com
Rosenblatt Maintains Buy on Dolby Laboratories, Maintains $85 Price Target

Rosenblatt analyst Steven Frankel maintains Dolby Laboratories (NYSE:DLB) with a Buy and maintain

benzinga.com
Dolby Laboratories Raises FY2026 GAAP EPS Guidance from $2.61-$2.76 to $2.71-$2.86 vs $2.78 Est

Dolby Laboratories (NYSE:DLB) raises FY2026 GAAP EPS guidance from $2.61-$2.76 to $2.71-$2.86 vs $2.

benzinga.com
Dolby Laboratories Raises FY2026 Adj EPS Guidance from $4.19-$4.34 to $4.30-$4.45 vs $4.23 Est; Rais

Dolby Laboratories (NYSE:DLB) raises FY2026 Adj EPS guidance from $4.19-$4.34 to $4.30-$4.45 vs $4.2

benzinga.com
Dolby Laboratories Sees Q2 Adj EPS $1.29-$1.44 vs $1.37 Est; Sees Sales $375.000M-$405.000M vs $379.

Dolby Laboratories (NYSE:DLB) is looking for Q2 Adj EPS of $1.29-$1.44 vs $1.37 analyst estimate. se

Dolby Laboratories: Q1 Earnings Insights
benzinga.com
Dolby Laboratories: Q1 Earnings Insights

benzinga.com
Dolby Laboratories Q1 Adj. EPS $1.06 Beats $0.88 Estimate, Sales $346.706M Beat $332.073M Estimate

Dolby Laboratories (NYSE:DLB) reported quarterly earnings of $1.06 per share which beat the analyst

Earnings Scheduled For January 29, 2026
benzinga.com
Earnings Scheduled For January 29, 2026

An Overview of Dolby Laboratories's Earnings
benzinga.com
An Overview of Dolby Laboratories's Earnings

What Analysts Are Saying About Dolby Laboratories Stock
benzinga.com
What Analysts Are Saying About Dolby Laboratories Stock

benzinga.com
Rosenblatt Maintains Buy on Dolby Laboratories, Maintains $85 Price Target

Rosenblatt analyst Steven Frankel maintains Dolby Laboratories (NYSE:DLB) with a Buy and maintain

benzinga.com
From Flat To Full Immersion: The AWS Path To Dolby Vision And Dolby Atmos

https://aws.amazon.com/blogs/media/from-flat-to-full-immersion-the-aws-path-to-dolby-vision-and-dolb

benzinga.com
Rosenblatt Maintains Buy on Dolby Laboratories, Lowers Price Target to $85

Rosenblatt analyst Steven Frankel maintains Dolby Laboratories (NYSE:DLB) with a Buy and lowers t

benzinga.com
Dolby Laboratories Sees FY2026 Adj EPS $4.19-$4.34 vs $3.96 Est; Sees Sales $1.390B-$1.440B vs $1.34

Dolby Laboratories (NYSE:DLB) is looking for FY2026 Adj EPS of $4.19-$4.34 vs $3.96 analyst estimate